Dr. Charles (Chuck) Silberstein, M.D., MBA, CFA, joined Applied Therapeutics as Chief Financial Officer and Head of Business Development in May 2020. Dr. Silberstein formerly served as Senior Vice President of Corporate Business Development at Allergan plc (acquired by AbbVie). Along with broad corporate strategy and business development skills, Dr. Silberstein brings more than 20 years of investment and capital markets experience to Applied Therapeutics, as a portfolio manager at The Boston Company Asset Management and Goldman Sachs Asset Management and as a senior healthcare equity analyst at JP Morgan Asset Management. Dr. Silberstein received his M.D. from Albert Einstein College of Medicine and his MBA from Columbia Business School.